Healthcare

Audax plots secondaries build-out

Last year, the Boston mid-market GP carried out a $1.7bn process on its 2012-vintage fund, backed by AlpInvest, Lexington and Hamilton Lane.

Pantheon aims to fill mid-market ‘void’ with Fund VII target

The asset manager is targeting space left by the ballooning mega-fund market, according to documents from US public pension fund VCERA.

Distressed specialist Multiplicity closes third fund

The Zurich-headquartered firm targets underperforming funds and those with limited upside to NAV across a range of asset classes.

CVC, Glendower confirm tie-up amid secondaries M&A fever

The secondaries specialist, which spun out of Deutsche Asset Management, is at least the fifth secondaries firm to be subject to an M&A process this year.

RCP hires exec to manage diversity and inclusion fund

Mary Hunt will advise on diversity, equity and inclusion in the Chicago manager’s portfolio and manage a new fund focused on the area.

In conversation with Dechert’s Michael Wong

The Hong Kong-based partner reflects on how debt secondaries are maturing in Asia-Pacific and his role in Ping An and Coller Capital’s recent credit secondaries deal.

Committed Advisors, Eurazeo back Capvis GP-led

Around half the LPs in the 2008-vintage €608m Capvis Equity III rolled over into the continuation vehicle.

RCP sets $650m hard-cap for fourth fund

The lower mid-market firm was targeting $150m for an overage fund to take advantage of opportunities brought about covid-19.